Pollux study
WebJan 4, 2024 · PURPOSE With the initial analysis of POLLUX at a median follow-up of 13.5 months, daratumumab in combination with lenalidomide and dexamethasone (D-Rd) … WebMar 1, 2024 · DOI: 10.1016/j.clml.2024.02.006 Corpus ID: 257339228; Comparative Efficacy of Teclistamab Versus Physician's Choice of Therapy in the Long-term Follow-up of APOLLO, POLLUX, CASTOR, and EQUULEUS Clinical Trials in Patients With Triple-class Exposed Relapsed or Refractory Multiple Myeloma.
Pollux study
Did you know?
WebNov 4, 2024 · Aim: Treatment options for triple-class exposed (TCE) patients with multiple myeloma (MM) in Japan are limited. Materials & methods: Retrospective observational study using the Medical Data Vision database (April 2008–April 2024). Eligible adults with MM received a new post-TCE treatment. Treatments, healthcare resource utilization … WebJan 17, 2024 · The POLLUX study is a randomized international phase III trial. Again, the highest level of evidence will be used when we assess drugs. It’s based on lenalidomide and dexamethasone in both arms, and the experimental arm has the addition of daratumumab. The results show a median follow-up of 13.5 months.
WebFeb 10, 2024 · Four of these studies involved daratumumab (POLLUX, CASTOR, CANDOR, APOLLO), and two involved isatuximab (ICARIA and IKEMA) as the anti-CD38 monoclonal antibody. It is not surprising, given the single-agent activity of both daratumumab and isatuximab, that all six of these studies have demonstrated … WebPollux Technologies Ltd. Feb 2024 - Present1 year 3 months. Dhaka, Bangladesh. • Conducting and assessing training program for 15 employees. • Creating a healthy working environment by versatile communication which ensures trust and transparency among employees. • Managing employee’s attendance and leave management.
WebCastor & Pollux provides dividend imputation to Australian-resident shareholders from its Australian tax paid. Assume that Castor & Pollux pays a 85% partly-franked dividend of $14.32 thousand to an Australian shareholder who currently has a taxable income of $250 thousand before dividends and a marginal tax rate of 32.5% and is NOT exempted from … WebThe lead investigator of the POLLUX study, Meletios A. Dimopoulos from the Athens School of Medicine, Athens, Greece, and colleagues, continued to follow up on the PFS …
WebOct 29, 2024 · Patients and Study Designs. Population PK analyses were performed on combined datasets from four clinical studies: CASTOR (MMY3004; ClinicalTrials.gov identifier, NCT02136134), POLLUX (MMY3003; NCT02076009), GEN503 (NCT01615029), and EQUULEUS (MMY1001; NCT01998971), all of which have been described in detail …
WebI extend video game music that I enjoy listening to. I made a new channel since my old one was terminated. Any ads you see on my videos are not placed by me. connwcting zenith dtv to computerconnweld facebookWebJun 13, 2016 · The phase 3 POLLUX study was conducted in 569 patients with RMM who had received at least one previous line of therapy (19% had received three or more). Median age was 65 years. conn weather nbcWebJul 2, 2024 · While this study could not definitively show benefit of Dara in ND HRD, the admittedly smaller sample size resulted in wide confidence intervals. Another potential reason is that the relapsed/refractory studies (POLLUX and CASTOR) both have doublets in the control arm, which are inferior to triplets. edith weston pubWebApr 6, 2024 · Details of the POLLUX study have been described previously. 11 Briefly, POLLUX is a randomized, open-label, active-controlled, parallel-group, multicentre, phase 3 study in patients with RRMM. Adult patients with RRMM were randomized in a 1:1 ratio to receive continued treatment cycles (one cycle = 28 days) of D-Rd or Rd until disease … conn weather nowWebThe open-label, randomized POLLUX trial compared safety and efficacy of lenalidomide and dexamethasone with or without daratumumab in 569 patients with RRMM (median age = … conn williamsonWebPollux has an extrasolar planet revolving around it, as do two other stars in Gemini, HD 50554, and HD 59686. γ Gem (Alhena) is a blue-white hued star of magnitude 1.9, 105 light-years from Earth. ... A study published in 1990 suggests the star involved was 1 Geminorum and the event took place on 5 December 337 BC. edith weston weather